Common genetic variation contributes significantly to the risk of developing chronic lymphocytic leukemia

Recent genome-wide association studies (GWAS) have identified common genetic risk variants for chronic lymphocytic leukemia (CLL).[1][1]–[3][2] Testing SNPs individually for an association in GWAS necessitates the imposition of a very stringent P value to address multiple testing. While this